For generations, waking up with a persistent headache, battling jittery anxiety, or struggling to keep your eyes open at work despite a full night in bed has been chalked up to the routine stressors of womanhood. From the cyclical disruptions of menstruation and the hormonal shifts of the menopause transition to the demanding realities of motherhood, the list of suspected culprits is long and familiar. However, medical experts warn that these vague, everyday symptoms could actually stem from a serious health condition that has historically been dismissed as a "male disease": obstructive sleep apnea, or OSA.
If you immediately picture an older man dozing off on a living room couch and snoring loudly like a lawn mower, you are far from alone. For decades, medical understanding of sleep apnea was built almost entirely around male physiology and presentation. It was not until the 1990s that researchers first recognized that OSA, a disorder characterized by the repeated collapse of the upper airway during sleep, often presents in entirely different ways in women. Most notably, many women suffering from the condition do not snore at all.
While researchers are still working to fully understand the biology underlying these distinctions, current evidence suggests that a complex interplay of hormonal fluctuations throughout a woman’s lifespan, differences in upper airway anatomy, and persistent social stigmas regarding how women are expected to sleep all play significant roles.
Dr. Jennifer Martin, a behavioral sleep medicine specialist and professor at Florida International University’s Herbert Wertheim College of Medicine in Miami, points out the foundational bias in how the medical community approaches the disorder. The disease itself was defined based on men, she explains, noting that the mechanics of how men and women breathe during sleep are fundamentally different, yet standard diagnostic definitions fail to account for that divergence.
Although obstructive sleep apnea appears statistically less common and typically milder in women—at least prior to menopause—clinical studies suggest that the long-term consequences of the disease, if left untreated, can be just as severe, and potentially worse, compared to men. This reality makes recognizing the signs and seeking appropriate medical advocacy vital for female patients.
How and Why Sleep Apnea Differs in Women
Sleep apnea sits under the broader umbrella of sleep-disordered breathing conditions. The most prevalent form is OSA, which occurs when the upper airway repeatedly collapses during slumber, restricting the flow of air to the lungs, according to Dr. Anita Valanju Shelgikar, a sleep medicine physician with University of Michigan Health and president of the American Academy of Sleep Medicine.
The textbook symptoms of OSA—established through research heavily weighted toward male participants—include loud snoring and dramatic gasps for air as the sleeper struggles to keep breathing. However, Dr. Shelgikar notes that this picture rarely reflects the experience of female patients. Instead, women dealing with OSA are significantly more likely to experience nightmares, frequent nighttime awakenings, difficulties staying asleep, and chronic insomnia. These disruptions subsequently manifest as daytime fatigue, morning headaches, and noticeable mood swings. Furthermore, women tend to experience a higher frequency of hypopneas, which are shallow breaths accompanied by reduced oxygen flow, whereas men are more prone to full apneas, representing complete pauses in breathing.
Some experts speculate that snoring may be less frequently reported among women due to social embarrassment, given that societal expectations often project an idealized image of peaceful, quiet rest for women. Yet, a growing body of scientific literature suggests that biological factors provide a much more robust explanation for these sex-related differences. Compared to men, women generally possess smaller, structurally more stable airways that are less prone to collapse and the subsequent tissue vibration that causes loud snoring. Women also typically carry less fat distribution around their necks. Furthermore, during their premenopausal years, women appear to benefit from the protective physiological effects of estrogen and progesterone, hormones that interact with the respiratory system in a manner that supports stable breathing.
Considering these factors, it is unsurprising that national data indicates more men than women in the United States live with the condition, accounting for approximately 59% and 41% of obstructive sleep apnea patients, respectively. However, once women undergo menopause and experience a natural decline in estrogen and progesterone levels, the prevalence of OSA and the severity of its symptoms increase dramatically. Research indicates that between 47% and 67% of postmenopausal women suffer from obstructive sleep apnea, putting them on par with men aged 50 and older. Despite these high prevalence rates, the number of women who actually receive an official diagnosis remains disproportionately low.
Regardless of age, women continue to grapple with a greater burden of sleep apnea-related symptoms than men, even when presenting with a milder form of the physiological condition. Dr. Martin attributes this to the fact that women experience more subtle, frequent breathing disturbances throughout the night that cumulatively degrade the overall restorative quality of their rest.
Why Misdiagnoses are Common in Women with Sleep Apnea
Because women frequently fail to exhibit the classic, male-centric symptoms of OSA, they are routinely misdiagnosed or dismissed by healthcare providers. When a male patient visits a physician reporting sleepiness and snoring, he is frequently fast-tracked for a diagnostic sleep study. In contrast, a woman who presents with complaints of poor sleep and profound daytime fatigue is much less likely to receive a referral for screening. In fact, existing research suggests that men are roughly nine times more likely to be referred for diagnostic testing than women.
When women seek help for symptoms tied to undiagnosed OSA, their complaints are frequently misattributed to depression, anxiety, insomnia, or the normal transitions of menopause, or even written off as medication side effects, according to Dr. Shelgikar, who is also a neurology professor at the University of Michigan Medical School. Compounding the issue, women can experience these mental health and sleep disorders concurrently, which can both obscure the presence of sleep apnea and worsen its severity.
This creates a difficult diagnostic tangle, particularly with the intersection of insomnia and OSA. Having both conditions simultaneously is more prevalent among women than men, and clinicians may sometimes prescribe sleep aids, such as diphenhydramine or benzodiazepines, to address the insomnia. Unfortunately, these medications can further relax throat muscles, exacerbating the underlying sleep apnea and leaving the patient even more deprived of oxygen.
The diagnostic criteria themselves present another systemic hurdle. The standard benchmarks used to diagnose OSA require either a breathing interruption accompanied by a measurable drop in blood oxygen levels or a brief micro-awakening from sleep. Because women often do not experience the same steep drops in oxygen saturation seen in men, the established parameters for the disease inherently bias medical evaluation toward male patients.
This male-centric framework extends into institutional coverage as well. Medicare, the federal health insurance program relied upon by the vast majority of Americans aged 65 and older, generally only recognizes a sleep apnea diagnosis if the patient demonstrates those sharp, documented drops in blood oxygen levels. Typical mid-slumber wake-ups and subtle breathing irregularities often do not count on their own, meaning the official criteria enforced by major insurers remain fundamentally tied to male physiological presentations.
Furthermore, home sleep apnea tests—increasingly utilized as a more affordable and convenient alternative to comprehensive in-lab polysomnography—are notoriously prone to missing the condition in female patients. Because women tend to have fewer and milder observable events, at-home monitors struggle to capture the full picture of their condition. These devices can be particularly inaccurate for women suffering from concurrent insomnia, as they may not sleep long enough during the monitoring period to yield a valid diagnostic sample.
Ultimately, these diagnostic blind spots mean that sleep apnea is likely far more prevalent among women than current health data indicates. This leaves countless women without the necessary medical interventions, allowing a treatable condition to cascade into an array of preventable health complications.
Why You Should Treat Your Sleep Apnea
If left unaddressed, obstructive sleep apnea can exert profound downstream effects on overall health, with the cardiovascular system bearing much of the burden, explains Dr. Atul Malhotra, research chief of pulmonary, critical care, and sleep medicine at UC San Diego Health. Every time a patient stops breathing, the body registers the oxygen deficit as an emergency, triggering the release of the stress hormone adrenaline to jolt the brain awake just enough to force a breath. These micro-awakenings happen so rapidly that the individual typically retains no memory of them the following morning.
Over time, this continuous nocturnal stress places immense strain on the cardiovascular system, elevating the long-term risk of high blood pressure, heart attack, stroke, irregular heartbeats, and heart failure. While clinical evidence remains mixed, some studies suggest that women with severe sleep apnea may experience cardiovascular complications at rates comparable to or exceeding those of men. Furthermore, research demonstrates that female patients often present with a higher burden of coexisting health conditions at the time of an OSA diagnosis, including thyroid disease, asthma, and depression. Whether sleep apnea acts as a catalyst or a consequence in these cases remains a complex medical question, but experts emphasize that treating the underlying OSA consistently improves overall health outcomes.
Beyond cardiovascular risks, the chronic fragmentation of sleep caused by untreated apnea is closely linked to memory lapses, cognitive difficulties, and diminished daytime alertness. These deficits can elevate the risk of accidents at work or on the road, particularly in safety-sensitive industries. Less frequently discussed is the heavy toll untreated sleep apnea takes on emotional well-being and daily functioning. Sleep medicine specialists note that the medical community has historically failed to consider sleep apnea as a root contributor to persistent mental health symptoms, even though targeted management of OSA has been shown to significantly alleviate anxiety and depression in many patients.
As the medical field continues to refine its understanding of how sleep disorders manifest across different sexes, specialists emphasize an encouraging takeaway: clinical evidence clearly indicates that women benefit just as much as men—if not more—from proper sleep apnea treatment, underscoring the importance of vigilance and self-advocacy in navigating the healthcare system.
